LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL)

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Gang ^a   Yu, Dongsheng ^b   Nian, Xue ^b   Liu, Junyi ^c   Koenig, Ronald J ^d   Xu, Bin ^d   Sheng, Liang ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; FOXO1 PROTEIN, HUMAN; LONG UNTRANSLATED RNA; SMALL INTERFERING RNA; STEROID RECEPTOR RNA ACTIVATOR, HUMAN; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL LIPASE;

ANIMAL; DIET RESTRICTION; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; HUMAN; KNOCKOUT MOUSE; LIPID DIET; LIPID PEROXIDATION; LIVER; LIVER CELL; METABOLISM; MOUSE; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ANIMALS; CARRIER PROTEINS; DIET, HIGH-FAT; FASTING; FATTY LIVER; FORKHEAD BOX PROTEIN O1; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPASE; LIPID PEROXIDATION; LIVER; MICE; MICE, KNOCKOUT; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RNA, LONG NONCODING; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84992147616     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep35531     Document Type: Article

References (54)

1. Marchesini, G. et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1844-1850 (2001).
2. Youssef, W., Mccullough, A. J. Diabetes mellitus, obesity, hepatic steatosis. Seminars in Gastrointestinal Disease 13, 17-30 (2002).
3. Rinella, M. E. Nonalcoholic fatty liver disease: a systematic review. Jama the Journal of the American Medical Association 313, 2263-2273 (2015).
4. Shaker, M., Tabbaa, A., Albeldawi, M., Alkhouri, N. Liver transplantation for nonalcoholic fatty liver disease: New challenges and new opportunities. World Journal of Gastroenterology 20, 5320-5330 (2014).
5. Ruhl, C. E., Everhart, J. E. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Alimentary Pharmacology & Therapeutics 41, 65-76 (2015).
6. Goldberg, I. J., Ginsberg, H. N. Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology 130, 1343-1346 (2006).
7. Reid, B. N. et al. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, ameliorates steatosis. Journal of Biological Chemistry 283, 13087-13099 (2008).
8. Wu, J. W. et al. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis † ‡. Hepatology 54, 122-132 (2011).
9. Ong, K. T., Mashek, M. T., Bu, S. Y., Greenberg, A. S., D. G. M. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning † ‡. Hepatology 53, 116-126 (2011).
10. Haemmerle, G. et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312, 734-737 (2006).
11. Kienesberger, P. C. et al. Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. Journal of Biological Chemistry 284, 30218-30229 (2009).
12. Rinn, J. L., Chang, H. Y. Genome regulation by long noncoding RNAs. Annual Review of Biochemistry 81, 145-166 (2012).
13. Wang, X., Song, X., Glass, C. K., Rosenfeld, M. G. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs. Cold Spring Harbor Perspectives in Biology 3, a003756-a003756 (2011).
14. Li, P. et al. A Liver-Enriched Long Non-Coding RNA, lncLSTR, Regulates Systemic Lipid Metabolism in Mice. Cell metabolism 21, 455-467 (2015).
15. Lanz, R. B. et al. A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex. Cell 97, 17-27 (1999).
16. Xu, B., Koenig, R. J. An RNA-binding domain in the thyroid hormone receptor enhances transcriptional activation. Journal of Biological Chemistry 279, 33051-33056 (2004).
17. Zhao, X. et al. Regulation of Nuclear Receptor Activity by a Pseudouridine Synthase through Posttranscriptional Modification of Steroid Receptor RNA Activator. Molecular Cell 15, 549-558 (2004).
18. Caretti, G. et al. The RNA Helicases p68/p72 and the Noncoding RNA SRA Are Coregulators of MyoD and Skeletal Muscle Differentiation. Developmental Cell 11, 547-560 (2006).
19. Hubé, F., Velasco, G., Rollin, J., Furling, D., Francastel, C. Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation. Nucleic Acids Research 39, 513-525 (2011).
20. Xu, B. et al. Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Molecular & Cellular Biology 29, 1719-1734 (2009).
21. Lanz, R. B., Razani, B., Goldberg, A. D., O'Malley, B. W. Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). Proceedings of the National Academy of Sciences 99, 16081-16086 (2002).
22. Leygue, E., Dotzlaw, H., Watson, P. H., Murphy, L. C. Expression of the steroid receptor RNA activator in human breast tumors. Cancer Research 59, 4190-4193 (1999).
23. Murphy, L. C. et al. Altered expression of estrogen receptor coregulators during human breast tumorigenesis. Cancer Research 60, 6266-6271 (2000).
24. Friedrichs, F. et al. HBEGF, SRA1, IK: Three cosegregating genes as determinants of cardiomyopathy. Genome Research 19, 395-403 (2009).
25. E, E. et al. Identification of new human coding steroid receptor RNA activator isoforms. Biochemical & Biophysical Research Communications 301, 509-515 (2003).
26. Kawashima, H. et al. A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochemical Journal 369, 163-171 (2003).
27. Xu, B. et al. Multiple Roles for the Non-Coding RNA SRA in Regulation of Adipogenesis and Insulin Sensitivity. Plos One 5, e14199 (2010).
28. Liu, S. et al. SRA Regulates Adipogenesis by Modulating p38/JNK Phosphorylation and Stimulating Insulin Receptor Gene Expression and Downstream Signaling. Plos One 9, e95416 (2014).
29. Liu, S. et al. SRA gene knockout protects against diet-induced obesity and improves glucose tolerance. Journal of Biological Chemistry 289, 13000-13009 (2014).
30. Cortés, V. A., Fernández-Galilea, M. Lipodystrophies: adipose tissue disorders with severe metabolic implications. Journal of Physiology & Biochemistry 71, 1-8 (2015).
31. Roman, S. et al. Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders. Translational Research 165, 464-479 (2015).
32. Villena, J. A., Roy, S., Sarkadi-Nagy, E., Kim, K. H., Sul, H. S. Desnutrin, an adipocyte gene encoding a novel patatin domaincontaining protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. Journal of Biological Chemistry 279, 47066-47075 (2004).
33. Chakrabarti, P., Kandror, K. V. FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. Journal of Biological Chemistry 284, 13296-13300 (2009).
34. Cook, J. R. et al. A Mutant Allele Encoding DNA Binding-Deficient FoxO1 Differentially Regulates Hepatic Glucose and Lipid Metabolism. Diabetes 64, 1951-1965 (2015).
35. Matsumoto, M., Han, S., Kitamura, T., Accili, D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. Journal of Clinical Investigation 116, 2464-2472 (2006).
36. Lp, V. D. H., Hoekman, M. F., Smidt, M. P. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochemical Journal 380, 297-309 (2004).
37. Huang, H., Tindall, D. J. Regulation of FOXO protein stability via ubiquitination and proteasome degradation . Biochimica Et Biophysica Acta 1813, 1961-1964 (2011).
38. Matsuzaki, H., Fukamizu, A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proceedings of the National Academy of Sciences of the United States of America 100, 11285-11290 (2003).
39. Kim, J. Y., Tillison, K., Lee, J. H., Rearick, D. A., Smas, C. M. The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma. American Journal of Physiology Endocrinology & Metabolism 291, E115-E127 (2006).
40. Matsusue, K. et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. Journal of Clinical Investigation 111, 737-747 (2003).
41. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, expression. Genome Research 22, 1775-1789 (2012).
42. Mitchell, G. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227 (2009).
43. Guttman, M., Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339-346 (2012).
44. Watanabe, M. et al. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. Embo Journal 20, 1341-1352 (2001).
45. Xu, B., Koenig, R. J. Regulation of thyroid hormone receptor 2 RNA binding and subcellular localization by phosphorylation. Molecular & Cellular Endocrinology 245, 147-157 (2005).
46. Zimmermann, R. et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306, 1383-1386 (2004).
47. Kershaw, E. E. et al. PPAR regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. American Journal of Physiology Endocrinology & Metabolism 293, 1736-1745 (2007).
48. Caretti, G., Lei, E. P., Sartorelli, V. The DEAD-Box p68/p72 Proteins and the Noncoding RNA Steroid Receptor Activator SRA: Eclectic Regulators of Disparate Biological Functions. Cell cycle 6, 1172-1176 (2007).
49. Shi, Y. et al. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes & Development 15, 1140-1151 (2001).
50. Hatchell, E. C. et al. SLIRP, a Small SRA Binding Protein, Is a Nuclear Receptor Corepressor. Molecular Cell 22, 657-668 (2006).
51. Vicent, G. P. et al. Unliganded progesterone receptor-mediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes. Genes & Development 27, 1179-1197 (2013).
52. Wongtrakoongate, P., Riddick, G., Fucharoen, S., Felsenfeld, G. Association of the Long Non-coding RNA Steroid Receptor RNA Activator (SRA) with TrxG and PRC2 Complexes. PLoS genetics 11 (2015).
53. Sheng, L. et al. NF-B-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nature Medicine 18, 943-949 (2012).
54. Puig, O., Tjian, R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes & Development 19, 2435-2446 (2005).